Overview

Comparison of Hepatic Directed Vesicle (HDV)-Insulin Lispro Versus Insulin Lispro to Further Improve Glycemic Control

Status:
Completed
Trial end date:
2018-03-18
Target enrollment:
Participant gender:
Summary
Multi-Center, double blind, active comparator controlled multiple dose safety, tolerability and efficacy study
Phase:
Phase 2
Details
Lead Sponsor:
Diasome Pharmaceuticals
Collaborator:
Integrium
Treatments:
Insulin
Insulin Lispro
Insulin, Globin Zinc